[1]
2015. Potential role of interleukin 28B-gene polymorphism and natural immune enhancer treatment response in chronic HCV patients. Journal of Biochemistry, Microbiology and Biotechnology. 3, 1 (Oct. 2015), 15–20. DOI:https://doi.org/10.54987/jobimb.v3i1.230.